RxDoctor Payments DataLook up a doctor →

Xembify: payments to doctors

Payments that named Xembify as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$3.1M
Providers
5,085
Transactions
25,848
Average per transaction
$118

The per-transaction average — $118 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,085 providers the average total is $601, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Grifols USA, LLC$2,971,49497.2%
Grifols Shared Services North America, Inc.$82,4482.7%
Grifols Therapeutics LLC$2,7000.1%
← All drugs & devices